Biopharma funding rebounds in 2026, but capital flows to lower-risk assets
M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges
M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges
The event is expected to bring together health and wellness enthusiasts for an afternoon of insights, learning and practical takeaways
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
The collaboration is focused on overcoming a major limitation in existing cancer drugs
Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities
Developed with Wondrlab India, the 10-episode series brings together healthcare experts, a cancer survivor, and filmmaker Amole Gupte to foster meaningful conversations
Union Health Minister calls for heightened vigilance, stronger public awareness campaigns, and district-specific action plans for the high-transmission season
One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally
CEO Stéphane Bancel framed the changes as essential to scaling the business
Subscribe To Our Newsletter & Stay Updated